Illinois

Showing 11-15 of 15 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2025 to 31-January-2027	$1,000,000.00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease.	The University of Chicago	Piotr Witkowski	Cures	01-September-2025 to 31-August-2029	$8,500,000.00
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics	The University of Chicago	Jacob Ryan Enriquez	Cures	01-March-2025 to 29-February-2028	$247,790.00
Investigating the role of integrated stress response in type 1 diabetes	The University of Chicago	Charanya Muralidharan	Cures	01-March-2023 to 28-February-2026	$209,066.00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling	The University of Chicago	Aly Khan	Cures	01-September-2025 to 31-August-2026	$150,000.00